Following a recent and successful increase in its global market presence, the Australian-based skin care brand attracts/receives a growth capital investment led by Unilever Ventures to accelerate growth
| SYDNEY, April 24, 2019 /PRNewswire/ -- Dr Roebuck’s, the results-driven, clean Australian skin care brand, has closed a financing round with Unilever Ventures. The brand, which launched in 2016, recently expanded to 20 countries globally and is sold in over 2,000 doors and online via strategic partnerships with Sephora, Shopper’s Drug Mart, Cult Beauty and SpaceNK.
With the company’s launch into Sephora Europe and Southeast Asia in April, it plans to scale its direct retail operations globally. The new capital will be used to accelerate the brand’s market growth, enhance the company’s infrastructure and strategically invest in product innovation and R&D. “Dr Roebuck’s appealed to us because it is a brand that really lives and breathes clean beauty and its Australian lifestyle roots,” says Rachel Harris, Director of Unilever Ventures. “We look forward to working with Kim, Zoe and Natalie to help further drive Dr Roebuck’s international growth plans.” Sisters Zoe and Kim Roebuck founded Dr Roebuck’s as a way to honor their parents, who, as physicians, created a one-of-a-kind clean, Australian-inspired formula that successfully treated their eczema and dry, sensitive skin. The original Dr Roebuck formula, which quickly developed a cult following in their hometown of Bondi Beach, serves as the foundation and inspiration for the brand’s diverse and innovative product line. Dr Roebuck’s made its initial appearance on U.S. shelves in 2018 and has continued to attract a devout American fanbase ever since. Today, Dr Roebuck’s products are available for purchase at Sephora stores nationwide and Sephora.com, as well as DrRoebucks.com. About Dr Roebuck’s: About Unilever Ventures:
SOURCE Dr Roebuck’s |
View original content to download multimedia:
